Cite
HARVARD Citation
Long, M. et al. (n.d.). S931 Initial 8-week Therapy with Tofacitinib in Moderate-to-Severe Ulcerative Colitis in a Real World Prospective Multicenter Study (TOUR). American journal of gastroenterology. pp. S441-S442. [Online].